For people with glaucoma, it can often feel like all hope is lost. You may have been told that there is no cure for this condition, or that you’re inevitably going to suffer from blindness sooner or later. However, none of this is true, and Bono’s experience with glaucoma serves as a good reminder. When Bono announced he had glaucoma, he revealed that he has had the condition for many years. He serves as a great example of how people with glaucoma can keep their sight and still lead very active lives if treated early and effectively. It shows how effective glaucoma treatments, such as medicated eye drops (NAC) and minimally invasive surgery can be.
NAC eye drops not only provide lubrication for eyes, but they also help to reduce the symptoms of cataracts and help reverse glaucoma. Using the same formula as brand name “CAN-C”, one of the most popular brand of eye drops, NAC is non-invasive and reverses glycation. Glycation is simply damage to long-lived cells, long-lasting proteins, such as crystallins of the lens and cornea of the eyes, may accumulate substantial damage over time. Specifically, cells such as the retina cells in the eyes. In-depth studies using the NAC drops have concluded that patients experienced a significant improvement in vision and eye health after using the drops. The effects didn’t wear off afterwards either – those involved in the study were able to enjoy continued relief for up to two years.
While many people believe that glaucoma will cause blindness, we now know that this isn’t 100% true. Yes, some people may become blind as a result of glaucoma, but many sufferers, including Bono, continue to enjoy their sight for years after being diagnosed. Since 1980, the number of people going blind from glaucoma has reduced by more than 50%, thanks to better technology and treatments. Although there is no known cure for glaucoma at the moment, that doesn’t mean that treatments don’t work. Products such as NAC eye drops are very effective in treating the condition and acting as a vision-enhancing tool.
By getting diagnosed earlier, you allow yourself to start treatment during the early stages when it might not be very bad. Bono, aged 54 when he released some details of his experience with glaucoma, said that he found out over 20 years ago that he had the condition. However, his sight has remained as a result of early diagnosis, effective treatments and regular check-ups.
When you reach 40, the chances of developing glaucoma increase, which is why regular eye examinations are so important. You might not see or feel any symptoms, but that doesn’t mean you’re definitely in the clear.
NAC eye drops are effective in the early stages of glaucoma but also if you’ve suffered for several years. They are a cost-effective solution to cataracts and other eye problems, and act as a natural anti-oxidant. The drops are safe for your eyes and provide the natural treatment which is needed.
Landmark research on a group of Russian patients, with an average age of 65 and suffering from age-related cataract, cantered on the use of NAC eye drops with a one percent concentration. The patients applied the drops into their eyes twice daily, for a period of six months. The study found:
• 41% of patients experienced a significant improvement in the ‘transmissivity’ of their lens – clouding had been reduced
• 90% reported improved and sharper vision.
• 89% showed enhanced glare sensitivity.
• And the patients reported few side effects.
Commenting on the research, Dr. Babizhayev said: “For most patients treated, drug tolerance was good and no side effects were specifically associated with the application of 1 percent NAC. What is more, no recurrence of cataract development occurred during the period of NAC application.
1.“N-Acetyl-Carnosine Lubricant Eye-Drops Possess All-in-one Universal Antioxidant Protective Effects.” – Babizhayev MA1, Micas P, Guiotto A, Kasus-Jacobi A. U.S. National Library of Medicine.
2.”Failure of common glycation assays to detect glycation by fructose” – Ahmed N, Furth AJ (July 1992). Clin. Chem. 38 (7): 1301–3. PMID 1623595.
3.N-Acetyl-Carnosine as a Therapeutic Tool to Manage Age-Related Cataracts in Human and in Canine Eyes. Mark A. Babizhayev, Anatoly l. Deyev, Velantina N. Yermakoava